2022
DOI: 10.1021/acs.jafc.2c06674
|View full text |Cite
|
Sign up to set email alerts
|

d-Arabitol Ameliorates Obesity and Metabolic Disorders via the Gut Microbiota–SCFAs–WAT Browning Axis

Abstract: D-Arabitol, which is typically found in mushrooms, lichens, and higher fungi, might play an effective role in alleviating visceral fat accumulation and insulin resistance particularly for its low calorie and glycemic index. However, the regulatory mechanisms of D-arabitol for alleviating obesity and associated metabolic disorders remain poorly understood. This study aimed to investigate and analyze the underlying relationship between D-arabitol-mediated gut microbiota and obesity. The results showed that D-ara… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 49 publications
0
5
0
Order By: Relevance
“…FL or GOS consumption increased the diversity of gut microbiota and also altered the structure of the microbes affected by feeding HFrD. Specifically, GOS or FL increased the alpha diversity of gut microbiota, reduced the levels of LPS-producing bacteria, and increased the levels of SCFAs-producing bacteria ( Parasutterella , Blautia , Ruminiclostridium_9 , Butyricimonas , Ruminiclostridium , Oscillibacter , Ruminococcaceae_UCG-004 , and Lachnospiraceae_NK4A136_group ), compared to the Fw group. In DSS-induced colitis, the differences in gut microbiota between the FL and GOS treatments were more pronounced in regular diet-fed mice, whereas the differences were not significant in HFrD-fed mice . This may explain why the ameliorative effects between GOS and FL are similar to those of mice with HFrD, which were different in mice with a regular diet.…”
Section: Discussionmentioning
confidence: 99%
“…FL or GOS consumption increased the diversity of gut microbiota and also altered the structure of the microbes affected by feeding HFrD. Specifically, GOS or FL increased the alpha diversity of gut microbiota, reduced the levels of LPS-producing bacteria, and increased the levels of SCFAs-producing bacteria ( Parasutterella , Blautia , Ruminiclostridium_9 , Butyricimonas , Ruminiclostridium , Oscillibacter , Ruminococcaceae_UCG-004 , and Lachnospiraceae_NK4A136_group ), compared to the Fw group. In DSS-induced colitis, the differences in gut microbiota between the FL and GOS treatments were more pronounced in regular diet-fed mice, whereas the differences were not significant in HFrD-fed mice . This may explain why the ameliorative effects between GOS and FL are similar to those of mice with HFrD, which were different in mice with a regular diet.…”
Section: Discussionmentioning
confidence: 99%
“…37 Phascolarctobacterium producing SCFAs can improve the function of the gastrointestinal tract and reduce the level of inflammation. 38 Likewise, a significant selective enhancement of Bacteroides , Ruminococcus , Parabacteroides , and Coprococcus genera in the NC group was found. Specifically, Parabacteroides is a dominant bacteria, and its primary metabolic end products are beneficial acetic acid and succinic acid, helpful to resist inflammation.…”
Section: Resultsmentioning
confidence: 84%
“…Furthermore, a remarkable reduction in HFD-induced total weight gain was also observed in the HPSIDF + IF group ( p < 0.001) (Figure B). Lee’s index is a useful tool for determining the degree of obesity. The HPSIDF + IF group dramatically reduced Lee’s index of HFD-fed mice in contrast with the IF ( p < 0.001) and HPSIDF ( p < 0.05) groups (Figure C). Besides, calorie intake and food efficiency ratio were higher in the HFD group (Figure D–F).…”
Section: Resultsmentioning
confidence: 97%